● Recruiting

TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors

Condition: Ovarian Sex Cord Stromal Tumor · Ovarian Neoplasms · Ovarian Cancer · Sponsor: Beihua Kong

PhasePhase 3

Planned participants132

Who can joinFemale, 14 Years to 65 Years

Healthy volunteersNo

About this study

Investigators will conduct the trial to determine whether paclitaxel and cisplatin (PT) has the same curative effects and less adverse effects than bleomycin, etoposide and cisplatin(BEP) among newly diagnosed ovarian malignant sex cord-stromal tumor patients after surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Beihua Kong, MD. PhD. · +8618560081888 · kongbeihua@sdu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Qilu Hospital of Shandong University

Jinan, Shandong, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02429700